Europe Sepsis Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

Name: Europe Sepsis Diagnostics Market
SKU: Medical Device
Rating: 4.9 (11 reviews)

The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028. It is estimated to record a CAGR of 9.3% from 2021 to 2028.

Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches Fuels Europe Sepsis Diagnostics Market Growth

Most of the diagnostic tests for sepsis are time-consuming and take up to 72 hours to provide results. In the era of molecular diagnosis for every kind of disease, the demand for rapid diagnostic tests for sepsis is rising. To fulfil this rising demand, many key players operating in the industry put efforts into developing innovative rapid diagnostic tests for sepsis. In September 2020, Barcelona-based Loop Diagnostics launched a point-of-care diagnosis platform. The platform aimed to replace the traditional methods of blood culture analysis and provide rapid results. Also, it can identify bacterial infections via blood-based markers and provide test results in two hours with a 99% accuracy rate. The cost of the diagnosis with this system is US$ 70. Moreover, the key players developed cost-effective diagnostic tests to overcome all the challenges associated with sepsis diagnosis. Inflammatix, a pioneering molecular diagnostics company, announced the publication of a health economic model. The model shows that the use of the company's HostDxTM Sepsis test is cost-effective as compared to standard methods. The test was performed on patients suspected of acute respiratory tract infections (ARTI) in emergency departments. The study was published in April 2020 in The Journal of Health Economics and Outcomes Research. The model informed hospital clinicians of the potential clinical and economic benefits of widespread adoption of the HostDx Sepsis test. Thus, the rising demand for rapid diagnostics tests led to product launches, which is expected to drive the Europe sepsis diagnostics market during the forecast period.

Europe Sepsis Diagnostics Market Overview

The Europe sepsis diagnostics market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Germany holds a significant market share in the Europe sepsis diagnostics market and is estimated to register a robust growth rate over the forecast period. Germany and the UK are expected to contribute majorly to the growth of the market in Europe. The Europe sepsis diagnostics market is expected to witness a significant growth during the forecast period due to factors such as the need for early diagnosis of sepsis, the high mortality rate of the medical condition, and its increasing prevalence.

Europe Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Europe Sepsis Diagnostics Market Segmentation

The Europe sepsis diagnostics market is segmented the basis of product, technology, method, test type, pathogen, end user, and country.

Based on product, the Europe sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.

Based on technology, the Europe sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.

Based on method, the Europe sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.

Based on test type, the Europe sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.

Based on pathogen, the Europe sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.

Based on end user, the Europe sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.

Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Germany dominated the market share in 2021.

Abbott; Axis-Shield Diagnostics Ltd; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; Luminex Corporation; T2 Biosystems, Inc.; and THERMO FISHER SCIENTIFIC INC.are among the leading companies operating in the Europe sepsis diagnostics market.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Sepsis Diagnostics Market – By Product

1.3.2 Europe Sepsis Diagnostics Market – By Technology

1.3.3 Europe Sepsis Diagnostics Market – By Method

1.3.4 Europe Sepsis Diagnostics Market – By Test Type

1.3.5 Europe Sepsis Diagnostics Market – By Pathogen

1.3.6 Europe Sepsis Diagnostics Market – By End User

1.3.7 Europe Sepsis Diagnostics Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Sepsis Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe PEST Analysis

4.3 Experts Opinion

5. Europe Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections

5.1.2 Increase in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2 Market Restraints

5.2.1 Absence of Skilled Professionals

5.3 Market Opportunities

5.3.1 Rise in Funding and Support for Sepsis Diagnostics Research

5.4 Future Trends

5.4.1 Growing Technological Advancements in Sepsis Diagnosis

5.5 Impact Analysis

6. Sepsis Diagnostics Market– Europe Analysis

6.1 Europe Sepsis Diagnostics Market Revenue Forecast and Analysis

7. Europe Sepsis Diagnostics Market – By Product

7.1 Overview

7.2 Europe Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3 Instruments

7.3.1 Overview

7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Reagents and Assays

7.4.1 Overview

7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Blood Culture Media

7.5.1 Overview

7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Software

7.6.1 Overview

7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Europe Sepsis Diagnostics Market – By Technology

8.1 Overview

8.2 Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3 Molecular Diagnostics

8.3.1 Overview

8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Polymerase Chain Reaction

8.3.2.1.1 Overview

8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1 Overview

8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Syndromic Panel-Based Testing

8.3.2.3.1 Overview

8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4 Microarrays

8.3.2.4.1 Overview

8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4 Flow Cytometry

8.4.1 Overview

8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5 Microfluidics

8.5.1 Overview

8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6 Immunoassay

8.6.1 Overview

8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7 Biomarkers

8.7.1 Overview

8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8 Microbiology

8.8.1 Overview

8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Sepsis Diagnostics Market – By Method

9.1 Overview

9.2 Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3 Automated Diagnostics

9.3.1 Overview

9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4 Conventional Diagnostics

9.4.1 Overview

9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Sepsis Diagnostics Market – By Test Type

10.1 Overview

10.2 Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3 Point-of-Care Tests

10.3.1 Overview

10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4 Laboratory Tests

10.4.1 Overview

10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Europe Sepsis Diagnostics Market – By Pathogen

11.1 Overview

11.2 Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3 Bacterial Sepsis

11.3.1 Overview

11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4 Fungal Sepsis

11.4.1 Overview

11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5 Others

11.5.1 Overview

11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Europe Sepsis Diagnostics Market – By End User

12.1 Overview

12.2 Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3 Hospitals

12.3.1 Overview

12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4 Pathology and Reference Laboratories

12.4.1 Overview

12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5 Others

12.5.1 Overview

12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Europe Sepsis Diagnostics Market – By Country Analysis

13.1 Europe: Sepsis Diagnostics Market

13.1.1 Overview

13.1.2 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.1.2.1 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.1 Overview

13.1.2.1.2 Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.3 Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.4 Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.4.1 Germany: Sepsis Diagnostics Market, by Molecular diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.5 Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.6 Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.7 Germany: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.8 Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.1 Overview

13.1.2.2.2 France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.3 France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.4 France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.4.1 France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.5 France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.6 France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.7 France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.8 France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.1 Overview

13.1.2.3.2 UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.3 UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.4 UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.4.1 UK: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.5 UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.6 UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.7 UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.8 UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.1 Overview

13.1.2.4.2 Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.3 Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.4 Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.4.1 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.5 Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.6 Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.7 Italy: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.4.8 Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.1 Overview

13.1.2.5.2 Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.3 Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.4 Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.4.1 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.5 Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.6 Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.7 Spain: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

13.1.2.5.8 Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.1 Overview

13.1.2.6.2 Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.4.1 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics– Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

13.1.2.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

14. Sepsis Diagnostics Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies in the Sepsis Diagnostics Market (%)

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 Abbott

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 F. HOFFMANN-LA ROCHE LTD.

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 Immunexpress Inc.

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 BD

15.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 Danaher (Beckman Coulter)

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Luminex Corporation

15.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 THERMO FISHER SCIENTIFIC INC.

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 bioMerieux SA

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 T2 Biosystems, Inc.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

15.10 Axis-Shield Diagnostics Ltd

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Products and Services

15.10.4 Financial Overview

15.10.5 SWOT Analysis

15.10.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2. Germany: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 3. Germany: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 4. Germany: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 5. Germany: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. Germany: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 7. Germany: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 8. France: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 9. France: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 10. France: Sepsis Diagnostics Market, by Molecular diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 11. France: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 12. France: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. France: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 14. France: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 15. UK: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 16. UK: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 17. UK: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 18. UK: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 19. UK: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 20. UK: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 21. UK: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. Italy: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23. Italy: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 24. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 25. Italy: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 26. Italy: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 27. Italy: Sepsis Diagnostics Market, by Pathogen– Revenue and Forecast to 2028 (US$ Million)

Table 28. Italy: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 29. Spain: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 30. Spain: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 31. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 32. Spain: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 33. Spain: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 34. Spain: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 35. Spain: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 36. Rest of Europe: Sepsis Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 37. Rest of Europe: Sepsis Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 38. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics – Revenue and Forecast to 2028 (US$ Million)

Table 39. Rest of Europe: Sepsis Diagnostics Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 40. Rest of Europe: Sepsis Diagnostics Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)

Table 41. Rest of Europe: Sepsis Diagnostics Market, by Pathogen – Revenue and Forecast to 2028 (US$ Million)

Table 42. Rest of Europe: Sepsis Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 43. Organic Developments in the Sepsis Diagnostics Market

Table 44. Inorganic Developments in the Sepsis Diagnostics Market

Table 45. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Sepsis Diagnostics Market Segmentation

Figure 2. Europe Sepsis Diagnostics Market, By Country

Figure 3. Europe Sepsis Diagnostics Market Overview

Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market

Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Europe: PEST Analysis

Figure 7. Europe Experts Opinion

Figure 8. Europe Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9. Europe Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2021- 2028

Figure 10. Europe Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)

Figure 11. Europe Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Europe Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Europe Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Europe Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

Figure 16. Europe Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17. Europe Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18. Europe Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19. Europe Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20. Europe Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21. Europe Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22. Europe Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. Europe Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Europe Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Europe Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26. Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

Figure 27. Europe Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28. Europe Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 29. Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

Figure 30. Europe Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31. Europe Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32. Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

Figure 33. Europe Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34. Europe Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 35. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36. Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

Figure 37. Europe Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 38. Europe Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 39. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40. Europe: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 41. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 42. Germany: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43. France: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44. UK: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45. Italy: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46. Spain: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47. Rest of Europe: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Growth Strategies in the Sepsis Diagnostics Market (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe sepsis diagnostics market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe sepsis diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000